Thoracoscopic Lobectomy: A Safe and Effective Strategy for Patients Receiving Induction Therapy for Non-Small Cell Lung Cancer

Rebecca P. Petersen(Duke Medical Center), DuyKhanh Pham(Duke Medical Center), Eric M. Toloza(Duke Medical Center), William R. Burfeind(Duke Medical Center), David H. Harpole(Duke Medical Center), Steven I. Hanish(Duke Medical Center), Thomas A. D’Amico(Duke Medical Center)
The Annals of Thoracic Surgery
June 24, 2006
10.1016/j.athoracsur.2006.02.051
Cited by 95Open Access
Full Text

Abstract

Related Papers

Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
The International Adjuvant Lung Cancer Trial Collaborative Group|New England Journal of Medicine|2004|2.4k
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Timothy Winton, Robert B. Livingston, David C. Johnson et al.|New England Journal of Medicine|2005|1.8k
A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
R. Rosell, José Gómez‐Codina, Carlos Camps et al.|New England Journal of Medicine|1994|1.3k
Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure
Itaru Nagahiro, Akio Andou, Motoi Aoe et al.|The Annals of Thoracic Surgery|2001|528
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
Jack A. Roth, E. Neely Atkinson, Frank V. Fossella et al.|Lung Cancer|1998|450